Oncolys BioPharma Inc. (4588.T)

JPY 602.0

(-1.79%)

Annual Balance Sheets

(In JPY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.04 Billion 2.65 Billion 4.29 Billion 2.79 Billion 4.38 Billion 3.43 Billion
Total Current Assets 1.95 Billion 2.6 Billion 4.19 Billion 2.54 Billion 3.82 Billion 2.61 Billion
Cash And Short Term Investments 1.53 Billion 1.71 Billion 3.45 Billion 2.06 Billion 3.34 Billion 2.46 Billion
Cash and Cash Equivalents 1.28 Billion 1.71 Billion 3.45 Billion 2.06 Billion 3.34 Billion 2.46 Billion
Short Term Investments 245.08 Million 245.07 Million 245.07 Million 245.07 Million 245.07 Million 245.06 Million
Net Receivables 101.74 Million 872.71 Million 731.62 Million 467.25 Million 467.77 Million 143.18 Million
Inventory 5.34 Million 24.24 Million 11.65 Million 10.47 Million 14.91 Million 11.06 Million
Other Current Assets 315.95 Million 506 Thousand 16 Thousand 22 Thousand 1.15 Million 732 Thousand
Total Non-Current Assets 84.71 Million 42.2 Million 93.86 Million 250.73 Million 553.62 Million 811.99 Million
Net PPE 20.99 Million 21.14 Million 21.22 Million 42.54 Million 39.35 Million 30.55 Million
Good Will And Intangible Assets - - - 650 Thousand 850 Thousand -
Good Will - - - - - -
Intangible Assets - - - 650 Thousand 850 Thousand -
Long-Term Investments 63.58 Million 21.03 Million 55.53 Million 143.52 Million 430.58 Million 780.55 Million
Tax Assets - - - -143.52 Million -430.58 Million -
Other Non Current Assets 139.99 Thousand 19 Thousand 17.1 Million 207.53 Million 513.42 Million 884 Thousand
Other Assets 1.00 1000.00 - 1000.00 - 2000.00
Total Liabilities 566.5 Million 491.69 Million 697.88 Million 793.08 Million 926 Million 528.95 Million
Total Current Liabilities 378.53 Million 321.63 Million 430.21 Million 415.24 Million 523.8 Million 212.32 Million
Account Payables 193.35 Million 60.85 Million 106.24 Million 206.61 Million 253.27 Million 71.01 Million
Tax Payables 18.84 Million 2.93 Million 59.24 Million 33.48 Million 119.68 Million 35.93 Million
Short Term Debt 135.34 Million 231.35 Million 241.55 Million 152.15 Million 130.92 Million 89.13 Million
Deferred Revenue -193.35 Million -60.85 Million -106.24 Million -206.61 Million -253.27 Million -71.01 Million
Other Current Liabilities 243.19 Million 90.28 Million 188.65 Million 263.09 Million 392.87 Million 123.19 Million
Total Non Current Liabilities 187.96 Million 170.05 Million 267.67 Million 377.84 Million 402.2 Million 316.63 Million
Long-Term Debt 161.1 Million 162.3 Million 261.91 Million 372.92 Million 397.29 Million 312.44 Million
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 26.86 Million 7.74 Million 5.75 Million 4.92 Million 4.9 Million 4.18 Million
Other Liabilities - - - - - -
Total Equity 1.47 Billion 2.15 Billion 3.59 Billion 2 Billion 3.45 Billion 2.9 Billion
Stock Holders Equity 1.47 Billion 2.15 Billion 3.59 Billion 2 Billion 3.45 Billion 2.9 Billion
Common Stock 3.62 Billion 3 Billion 9.03 Billion 7.43 Billion 7.12 Billion 6.4 Billion
Retained Earnings -3.37 Billion -1.43 Billion -14.51 Billion -12.9 Billion -10.8 Billion -9.89 Billion
Accumulated other comprehensive income 14.68 Million 7.68 Million 7.68 Million 7.49 Million 15.56 Million -2.79 Million
Common Stock Equity 1.47 Billion 2.15 Billion 3.59 Billion 2 Billion 3.45 Billion 2.9 Billion
Capital Lease Obligation 18.72 Million 10.33 Million 9.04 Million 8.41 Million 11.56 Million 7.14 Million
Total Investments 308.66 Million 21.03 Million 21.03 Million 112.47 Million 430.58 Million 769.45 Million
Total Debt 315.17 Million 393.65 Million 503.47 Million 525.07 Million 528.22 Million 401.58 Million
Net Debt -972.59 Million -1.31 Billion -2.95 Billion -1.54 Billion -2.81 Billion -2.06 Billion

Balance Sheet Charts